Ocular Therapeutix, Inc. (NASDAQ:OCUL) Receives Average Recommendation of “Moderate Buy” from Brokerages
Ocular Therapeutix, Inc. (NASDAQ:OCUL – Get Free Report) has received an average rating of “Moderate Buy” from the nine brokerages that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1-year price target […]
Ocular Therapeutix, Inc. (NASDAQ:OCUL – Get Free Report) has received an average rating of “Moderate Buy” from the nine brokerages that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1-year price target […]
